Inducible haemorrhage (epistaxis) secondary to lomustine administration without thrombocytopenia in a dog

Abstract A 13‐year‐old dog with no history of spontaneous bleeding was presented for evaluation of multiple diffusely distributed cutaneous mast cell tumours. No obvious metastasis was found, and chemotherapy with vinblastine/lomustine was initiated. After the second dose of lomustine was administered, the dog experienced epistaxis for 2–3 minutes per day along with heavy sneezing due to the discharge. Throughout additional chemotherapy cycles, intermittent nasal bleeding continued, and investigation into the causes of epistaxis found no obvious nasal causes or coagulopathies, but epistaxis resolved after lomustine administration was delayed. As the mast cell tumours began to grow again, another dose of lomustine was given without vinblastine, and epistaxis returned. Throughout the dog's treatment, it was never thrombocytopenic but often had thrombocytosis. There are reports of lomustine and other nitrosoureas affecting platelet function in people, and this could be considered a differential in dogs as well.

Authors

Institutions

Publication Details

Journal
Veterinary Record Case Reports
Published
2025-10-15
DOI
https://doi.org/10.1002/vrc2.70225
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inducible haemorrhage (epistaxis) secondary to lomustine administration without thrombocytopenia in a dog

Andrew Schlueter, Rance K. Sellon
Veterinary Record Case Reports
Platelet Disorders and Treatments
article

Inducible haemorrhage (epistaxis) secondary to lomustine administration without thrombocytopenia in a dog

Andrew Schlueter, Rance K. Sellon
article en

Abstract

Abstract A 13‐year‐old dog with no history of spontaneous bleeding was presented for evaluation of multiple diffusely distributed cutaneous mast cell tumours. No obvious metastasis was found, and chemotherapy with vinblastine/lomustine was initiated. After the second dose of lomustine was administered, the dog experienced epistaxis for 2–3 minutes per day along with heavy sneezing due to the discharge. Throughout additional chemotherapy cycles, intermittent nasal bleeding continued, and investigation into the causes of epistaxis found no obvious nasal causes or coagulopathies, but epistaxis resolved after lomustine administration was delayed. As the mast cell tumours began to grow again, another dose of lomustine was given without vinblastine, and epistaxis returned. Throughout the dog's treatment, it was never thrombocytopenic but often had thrombocytosis. There are reports of lomustine and other nitrosoureas affecting platelet function in people, and this could be considered a differential in dogs as well.

Veterinary Record Case ReportsVol. 13(4)
Washington State University (US)
Openalex Percentile: Top 63%
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Inducible haemorrhage (epistaxis) secondary to lomustine administration without thrombocytopenia in a dog — Andrew Schlueter, Rance K. Sellon · Veterinary Record Case Reports (2025) | TGRS Research Map | TGRS